Cerus Corporation - Common Stock (NQ:CERS)

2.035 -0.205 (-9.15%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 5, 2026 Add to My Watchlist

Price and Volume

Volume	2,731,051
Open	2.170
Bid (Size)	2.030 (34,800)
Ask (Size)	2.040 (20,300)
Prev. Close	2.240
Today's Range	2.010 - 2.190
52wk Range	1.120 - 2.955
Shares Outstanding	180,552,190
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Cerus Corp (NASDAQ:CERS) Reports Mixed Q4 2025 Results, Stock Falls on Revenue Miss ↗

March 02, 2026

Via Chartmill

Cerus (CERS) Q4 2025 Earnings Call Transcript ↗

March 02, 2026

Cerus (CERS) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Performance

YTD	+3.3%	+3.3%
1 Month	-12.3%	-12.3%
3 Month	+2.3%	+2.3%
6 Month	+55.3%	+55.3%
1 Year	+28.8%	+28.8%

More News

Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

March 02, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

February 20, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

February 17, 2026

From Cerus Corporation

Via Business Wire

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice

January 22, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook

January 11, 2026

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America

December 10, 2025

From Cerus Corporation

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 06, 2025

Via Benzinga

Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

November 06, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting

October 21, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

October 16, 2025

From Cerus Corporation

Via Business Wire

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

August 25, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

August 21, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Second Quarter 2025 Financial Results

August 05, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

July 22, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

July 21, 2025

From Cerus Corporation

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 02, 2025

Via Benzinga

Get insights into the top gainers and losers of Wednesday's after-hours session. ↗

July 02, 2025

Via Chartmill

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

July 02, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Celebrates World Blood Donor Day 2025

June 13, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

June 03, 2025

From Cerus Corporation

Via Business Wire

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

May 29, 2025

From Cerus Corporation

Via Business Wire

Frequently Asked Questions

Is Cerus Corporation - Common Stock publicly traded?

Yes, Cerus Corporation - Common Stock is publicly traded.

What exchange does Cerus Corporation - Common Stock trade on?

Cerus Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cerus Corporation - Common Stock?

The ticker symbol for Cerus Corporation - Common Stock is CERS on the Nasdaq Stock Market

What is the current price of Cerus Corporation - Common Stock?

The current price of Cerus Corporation - Common Stock is 2.035

When was Cerus Corporation - Common Stock last traded?

The last trade of Cerus Corporation - Common Stock was at 03/05/26 04:00 PM ET

What is the market capitalization of Cerus Corporation - Common Stock?

The market capitalization of Cerus Corporation - Common Stock is 367.42M

How many shares of Cerus Corporation - Common Stock are outstanding?

Cerus Corporation - Common Stock has 367M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.